Derma Sciences (DSCI) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts DSCI Hot Sheet
Price: $7.00 --0%
Financial Fact:
Total other expense: -230.57K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Total other expense: -230.57K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Derma Sciences (NASDAQ: DSCI) reported Q3 EPS of ($0.04), in-line with the analyst estimate of ($0.04). Revenue for the quarter came in at $21.8 million versus the consensus estimate of $23.9 million.
GUIDANCE:
Derma Sciences sees FY2016 revenue of $81.6 million, versus the consensus of $92.4 million.
For earnings history and earnings-related data on Derma Sciences (DSCI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
